Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.

Oncotarget
Wei-Qun LuWei Fan

Abstract

Clinical treatment for colorectal cancer (CRC) thus far encounters a huge challenge due to oxaliplatin-resistance. As crucial rate-limiting enzymes in aerobic glycolysis and glutaminolysis, pyruvate kinase M2 type (PKM2) and kidney-type glutaminase (GLS1) are proposed to carry important implications in colorectal carcinogenesis and drug-resistance. This study aimed to explore the possible association of oxaliplatin-resistance with aerobic glycolysis/glutaminolysis indexed by PKM2/GLS1 expression. PKM2 and GLS1 expression was quantified by polymerase chain reaction (PCR) and Western blot techniques in CRC cell lines. The abilities of cell formation, kinetics, migration, invasion, survival and apoptosis, as well as permeability glycoprotein (Pgp) expression were inspected before and after knocking-down PKM2/GLS1 expression. In addition, the influence of knocking-down PKM2/GLS1 expression was evaluated in vivo. Differentiated PKM2 and GLS1 expression in both THC8307 and THC8307/Oxa cell lines was identified. In the THC8307 cell line, PKM2 and GLS1 can accelerate malignant behaviors, increase oxaliplatin-resistance, upregulate Pgp expression, and inhibit cell apoptosis. Contrastingly in the THC8307/Oxa cell line, knockdown of PKM2/...Continue Reading

References

Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Oct 5, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T R WilsonP G Johnston
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Mar 20, 2010·Nature Reviews. Cancer·Daniel A TennantEyal Gottlieb
Jun 24, 2010·Trends in Biochemical Sciences·David R Wise, Craig B Thompson
Apr 25, 2012·Experimental and Therapeutic Medicine·Margaret E TomeMargaret M Briehl
Dec 13, 2012·Journal of Experimental & Clinical Cancer Research : CR·Yuan MaoZhen-Qing Feng
Aug 29, 2013·International Journal of Cancer. Journal International Du Cancer·Hong LinZhenqing Feng
Feb 14, 2014·Molecular Cancer Therapeutics·Matt I GrossMark K Bennett
Aug 8, 2014·Anti-cancer Agents in Medicinal Chemistry·Bryan T OronskyJan J Scicinski
Jan 28, 2015·Molecular Medicine Reports·Aiqin FuEnning Zhang
Jul 18, 2015·Molecular Cancer Therapeutics·Eva Martinez-BalibreaAlbert Abad
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Feb 3, 2016·International Journal of Cancer. Journal International Du Cancer·Elisabeth J KapJenny Chang-Claude
Feb 13, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Khalid O Alfarouk
Feb 20, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lili GuoChangyu Wang
Jul 8, 2016·Oncotarget·Ying ShiBayasi Guleng
Jul 23, 2016·Oncotarget·Hye Min KimJa Seung Koo

❮ Previous
Next ❯

Citations

Dec 4, 2019·Oncology Letters·Qiongli SuXiaoping Yang
Nov 2, 2019·International Journal of Molecular Sciences·Siyuan YanWancai Yang
Jun 27, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yang YuHaixia Guan
Dec 17, 2020·Frontiers in Cell and Developmental Biology·Jiasheng XuKefeng Ding
Jan 9, 2021·Neoplasia : an International Journal for Oncology Research·Fabrizio Marcucci, Cristiano Rumio
Oct 2, 2019·Cancer Letters·José M MatésJavier Márquez
Dec 10, 2020·Cancer Cell International·Xun ChenDongsheng Yu
May 1, 2019·Current Medicinal Chemistry·José M MatésJavier Márquez
May 24, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Wei YuYongJie Xin
Jun 9, 2021·Life Sciences·Abu Sufiyan Chhipa, Snehal Patel
Jul 25, 2021·International Journal of Molecular Sciences·Medhi WangpaichitrNiramol Savaraj

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
transfection

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.